Richard M. Soll
Corporate Officer/Principal at WUXI APPTEC CO., LTD.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Edward Hu | M | 61 | 17 years | |
Ge Li | M | 56 | 24 years | |
Zhao Hui Zhang | M | 54 | 24 years | |
Min Zhang Chen | M | 54 | - | |
Gabriel Groisman | M | - |
Children's Tumor Foundation
| 8 years |
Qing Yang | M | 55 | 9 years | |
Zhi Ling Zhan | F | 61 | 1 years | |
Annette Bakker | M | - |
Children's Tumor Foundation
| - |
Bo Yang Wu | M | 60 | 24 years | |
Wei Yu | M | 71 | 1 years | |
Harry He | M | 58 | 19 years | |
Ming Shi | F | 49 | 3 years | |
Tracy Galloway | F | - |
Children's Tumor Foundation
| - |
Yuanzhou Zhang | M | 35 | - | |
Xin Zhang | M | 47 | 1 years | |
Dai Feng | M | 48 | 6 years | |
Allan Rubenstein | M | 79 |
Children's Tumor Foundation
| - |
Richard Horvitz | M | - |
Children's Tumor Foundation
| - |
Robert B. Harrison | M | 60 |
Children's Tumor Foundation
| 2 years |
Randall Stanicky | M | 49 |
Children's Tumor Foundation
| 2 years |
Shao Hua Lu-Wong | F | 55 | 1 years | |
Florence Shi | F | 50 | 2 years | |
Yan Zhu | M | 60 | 11 years | |
Linda H. Martin | F | - |
Children's Tumor Foundation
| 17 years |
Guo Dong Tong | M | - | - | |
Anita Gribben | F | - |
Children's Tumor Foundation
| - |
Daniel T. Altman | M | - |
Children's Tumor Foundation
| - |
Kenneth Rudd | M | - |
Children's Tumor Foundation
| - |
Roger-Ketcha Ngassam | M | - |
Children's Tumor Foundation
| - |
Simone Manso | M | - |
Children's Tumor Foundation
| - |
Emily Parker | F | - |
Children's Tumor Foundation
| - |
Lu Le | M | - |
Children's Tumor Foundation
| - |
Scott Plotkin | M | - |
Children's Tumor Foundation
| - |
George Thuronyi | M | - |
Children's Tumor Foundation
| - |
D. Clapp | M | - |
Children's Tumor Foundation
| - |
Carol Kalagher | F | - |
Children's Tumor Foundation
| - |
John Golfinos | M | - |
Children's Tumor Foundation
| - |
Carolyn Castellano | F | - |
Children's Tumor Foundation
| - |
Sarah Coulam | F | - |
Children's Tumor Foundation
| - |
Garrett Gleeson | M | - |
Children's Tumor Foundation
| - |
Frank Haughton | M | - |
Children's Tumor Foundation
| - |
Daniel Gilbert | M | 62 |
Children's Tumor Foundation
| - |
Carolyn E. Setlow | F | - |
Children's Tumor Foundation
| - |
Joseph V. Hughes | M | - | - | |
Edward M. Stern | M | 65 |
Children's Tumor Foundation
| - |
Frederick Hausheer | M | - | 5 years | |
Xiao Meng Tong | M | 50 | 8 years | |
Steven L. McKenzie | M | - |
Children's Tumor Foundation
| - |
Sally Gottesman | F | - |
Children's Tumor Foundation
| - |
Ru Jian Ma | M | - | 23 years | |
Tao Guo | M | - | 16 years | |
Jing Chao Dong | M | - | 23 years | |
Yi Bing Wu | M | 55 | 8 years | |
Chi-Chung Chan | M | - | - | |
Hui Cai | M | - | - | |
Charles Z. Ding | M | - | - | |
Ellis Chu | M | - | - | |
Henry Lu | M | - | - | |
Maureen Speltz | M | - | - | |
Gong Hua Pan | M | - | - | |
Stuart Match Suna | M | - |
Children's Tumor Foundation
| - |
Wei Zhang | M | 52 | - | |
Felix Hsu | M | - | - | |
Ming Li Chen | M | - | - | |
Jerry Xu | M | - | - | |
Yuet Fan Cheung | F | 59 | 2 years | |
Elizabeth Rodbell | F | 67 |
Children's Tumor Foundation
| 2 years |
Min Fang Zhu | F | 53 | 23 years | |
Robert Brainin | M | 53 |
Children's Tumor Foundation
| - |
Michael Morin | M | 69 |
Children's Tumor Foundation
| - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Thomas Peter Stagnaro | M | 81 |
3-Dimensional Pharmaceuticals, Inc.
3-Dimensional Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology 3-Dimensional Pharmaceuticals, Inc. was acquired by Johnson & Johnson. 3-Dimensional Pharmaceuticals, Inc. operates as a drug discovery and development company that has a pipeline of drug candidates in the areas of cancer and inflammation, and metabolic and cardiovascular diseases | 6 years |
David C. U'Prichard | M | 75 |
3-Dimensional Pharmaceuticals, Inc.
3-Dimensional Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology 3-Dimensional Pharmaceuticals, Inc. was acquired by Johnson & Johnson. 3-Dimensional Pharmaceuticals, Inc. operates as a drug discovery and development company that has a pipeline of drug candidates in the areas of cancer and inflammation, and metabolic and cardiovascular diseases | 4 years |
Paul Weiss | M | 66 |
3-Dimensional Pharmaceuticals, Inc.
3-Dimensional Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology 3-Dimensional Pharmaceuticals, Inc. was acquired by Johnson & Johnson. 3-Dimensional Pharmaceuticals, Inc. operates as a drug discovery and development company that has a pipeline of drug candidates in the areas of cancer and inflammation, and metabolic and cardiovascular diseases | 3 years |
William D. Claypool | M | 72 |
3-Dimensional Pharmaceuticals, Inc.
3-Dimensional Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology 3-Dimensional Pharmaceuticals, Inc. was acquired by Johnson & Johnson. 3-Dimensional Pharmaceuticals, Inc. operates as a drug discovery and development company that has a pipeline of drug candidates in the areas of cancer and inflammation, and metabolic and cardiovascular diseases | 1 years |
Charles Theuer | M | 60 |
TargeGen, Inc.
TargeGen, Inc. Pharmaceuticals: MajorHealth Technology TargeGen, Inc. manufactures vascular biopharmaceutical products. The company was founded by David A. Cheresh and Peter G. Ulrich in 2001 and is headquartered in San Diego, CA. | 2 years |
Geoffrey E. Barker | M | - |
TargeGen, Inc.
TargeGen, Inc. Pharmaceuticals: MajorHealth Technology TargeGen, Inc. manufactures vascular biopharmaceutical products. The company was founded by David A. Cheresh and Peter G. Ulrich in 2001 and is headquartered in San Diego, CA. | 5 years |
Glenn Noronha | M | 59 |
TargeGen, Inc.
TargeGen, Inc. Pharmaceuticals: MajorHealth Technology TargeGen, Inc. manufactures vascular biopharmaceutical products. The company was founded by David A. Cheresh and Peter G. Ulrich in 2001 and is headquartered in San Diego, CA. | 6 years |
Jürgen Eckhardt | M | 57 |
TargeGen, Inc.
TargeGen, Inc. Pharmaceuticals: MajorHealth Technology TargeGen, Inc. manufactures vascular biopharmaceutical products. The company was founded by David A. Cheresh and Peter G. Ulrich in 2001 and is headquartered in San Diego, CA. | 5 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 41 | 52.56% |
China | 37 | 47.44% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Richard M. Soll
- Personal Network